Recombinant Anti-Human FAP Antibody (Fc glycosylation/Non fucosylated) (CAT#: Gly-150LC)

This product is a non-glycosylated human monoclonal antibody with glycosylation site in the Fc region. The antibody 28H1 with enhanced ADCC specifically binds human FAP and can be potentially used in the treatment of breast cancer, colon adenocarcinomas and NSCLC.

Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
Normal Tissue
RNA Expression

Glyco-engineering

  • Glycosylation site
  • Fc region
  • Glycosylation Type
  • N-glycosylation
  • Activity
  • Enhanced ADCC

Specifications

  • Target
  • FAP (Fibroblast Activation Protein)
  • Host Species
  • Human
  • Type
  • Human antibody
  • Specificity
  • Human
  • Antibody Isotype
  • IgG1
  • Clone
  • 28H1
  • Expression Host
  • HEK293-EBNA
  • Applications
  • ELISA

Target

  • Alternative Names
  • FAP; fibroblast activation protein, alpha; FAPA; SIMP; DPPIV; prolyl endopeptidase FAP; seprase; FAPalpha; dipeptidyl peptidase FAP; surface-expressed protease; post-proline cleaving enzyme; gelatine degradation protease FAP; integral membrane serine prot
  • Related Disease
  • Breast cancer, colon adenocarcinomas and NSCLC

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Clone 28H1"

See other products for "Fap"

Select a product category from the dropdown menu below to view related products.
Please select product type
Recombinant Antibody Humanized Antibody Human Antibody Low- or Non-fucosylated Oligosaccharide Fc Glycosylation scFv Fragment Antibody Fab Fragment Antibody Single-domain Antibody ADCC Enhanced Antibody MHC Tetramer for Cancer

Customer Reviews and Q&As

Customer Review Q&As

Submit a review or a question

  • Remarkable specificity and binding efficiency
    We've been using the Recombinant Anti-FAP Antibody with Fc glycosylation for our stromal cell studies and the results have been outstanding. The specificity and binding efficiency are remarkable, which has significantly enhanced the accuracy of our experiments. Highly recommended for anyone working in oncology research."
  • High affinity and specificity
    Switching to recombinant antibodies, especially the Anti-FAP with Fc glycosylation, has improved the quality of our cell separation techniques. The high affinity and specificity are exactly what we needed to achieve more precise results. Plus, knowing it's recombinant gives us peace of mind regarding consistency and batch-to-batch variation.

Popular products with customers


For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

  • 0
  • 0
Cart
    Go to compare

    Go to compare